Investors
Scale a working autonomous lab
Programmable Bio operates a compact autonomous R&D lab in Hyderabad. The financing case is to expand a functioning execution loop into customer capacity, a standardized assay catalog, and eventually a distributed programmable-biology network.
The deck is public. Figures explicitly marked as planning assumptions are illustrative drafts and must be replaced with verified company data before formal circulation.
Investment highlights
- Operational starting point — a compact autonomous R&D cell is running in Hyderabad today
- Clear use of capital — instruments, parallel capacity, assay standardization, software, and customer delivery
- Public price benchmark — launch targets match Ginkgo's published cloud-lab catalog
- Two customer paths — accessible academic pilots and higher-value industry capacity programs
- Programmable-biology data loop — structured execution records return evidence to computational design systems
- Clinical option, honestly scoped — an Apollo collaboration is proposed but no MoU is signed
See the competitive landscape for current source links and the platform page for operational status.
Start a conversation
Use this form for diligence, introductions, and strategic partnerships. Please do not include confidential, patient, or regulated information.